Dr Reddy’s Laboratories (RDY) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Dr. Reddy’s Laboratories Ltd. has been ordered to pay a tax demand including interest and penalty by the GST Authority, which the company received on August 30, 2024. The demand pertains to the financial years 2019-20 and 2020-21, concerning an alleged excess availed Input Tax Credit, resulting in a penalty of Rs.13,54,14,733. However, the company asserts that this will not materially impact its financials or operations, and plans to appeal the decision.
For further insights into RDY stock, check out TipRanks’ Stock Analysis page.